NCT00271635View on ClinicalTrials.gov

Ascorbic Acid Treatment in CMT1A Trial (AATIC)

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Charcot-Marie-Tooth DiseaseHereditary Motor and Sensory Neuropathies
Interventions
DRUG

Placebo

Placebo 4 capsules b.i.d. during 1 year

DRUG

ascorbic acid

Ascorbic acid 1000 mg (4 capsules of 250 mg) b.i.d. during 1 year

Trial Locations (1)

1100 DD

Department of Neurology Academic Medical Center University of Amsterdam, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT00271635 - Ascorbic Acid Treatment in CMT1A Trial (AATIC) | Biotech Hunter | Biotech Hunter